| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash (used in) provided by financing activities | -5,105 | -5,093 |
| Effect of exchange rates on cash and cash equivalents | 217 | 286 |
| Net decrease in cash and cash equivalents | -21,633 | -18,849 |
| Cash and cash equivalents at beginning of period | 65,594 | - |
| Cash and cash equivalents at end of period | 43,961 | - |
Cardlytics, Inc. (CDLX)
Cardlytics, Inc. (CDLX)